CRC
PPH icon

Curi RMB Capital’s VanEck Pharmaceutical ETF PPH Stock Holding History

Curi RMB Capital’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,896
Closed -$299K – 935
2025
Q4 		$299K Sell
2,896
-95
-3% -$9.24K 0.01% 754
2025
Q3 		$270K Buy
+2,991
New +$262K 0.01% 626

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Curi RMB Capital's PPH Position: Q1 2026 in Review

Curi RMB Capital sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2026, closing a stake of 2,896 shares — an estimated $299K sold.

Curi RMB Capital first reported a position in PPH in Q3 2025 and held it in 2 quarters. The position peaked at $299K in Q4 2025. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Curi RMB Capital reported no remaining VanEck Pharmaceutical ETF position as of Q1 2026 after selling out during the quarter.
  • Curi RMB Capital sold 2,896 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $299K.
  • Curi RMB Capital first reported a position in VanEck Pharmaceutical ETF in Q3 2025 and held it in 2 quarters.
  • Curi RMB Capital's VanEck Pharmaceutical ETF position peaked at $299K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Curi RMB Capital's 13F filing for Q1 2026, filed 15 May 2026.